A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation
- Resource Type
- Article
- Source
- In
Vaccine 4 November 2016 34(46):5571-5578 - Subject
- Language
- ISSN
- 0264-410X